Atropine and Pralidoxime Chloride, 'Duodote Kit"

The Department of Health and Human Services Office of the Assistant Secretary for Administration is requesting quotes for Atropine and Pralidoxime Chloride Autoinjector units, commonly known as "Duodote Kits," under National Drug Code (NDC) #11704-0620-01. This pharmaceutical procurement falls under the Drugs and Biologicals product service code and is classified within the Pharmaceutical Preparation Manufacturing industry sector. The solicitation was posted on December 3, 2025, with a response deadline of December 15, 2025, providing potential vendors with twelve days to submit their quotes. While the notice does not specify detailed evaluation criteria, vendors should anticipate that pricing, product authenticity, compliance with pharmaceutical regulations, and delivery capability will likely factor into the government's selection process. Interested contractors must be prepared to meet the abbreviated timeline and ensure their quotations address all requirements outlined in the formal request for quote.

This procurement carries no set-aside designation, meaning all eligible vendors may compete regardless of business size or ownership classification. The government requires 171 boxes of Duodote Kits, with each box containing 30 autoinjector units, for a total of 5,130 individual units. The delivery destination is the DHHS Shared Service Center Building #5 Receiving Dock, located at Fifth and Boilerhouse Road in Perry Point, Maryland 21902. No incumbent contractor, award value, or budget range has been identified in the available solicitation materials. Vendors must be capable of fulfilling this pharmaceutical delivery to the specified Maryland location and should prepare their quotes accordingly to meet the December 15, 2025 deadline.